SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000906709-20-000017
Filing Date
2020-11-06
Accepted
2020-11-05 20:43:07
Documents
50
Period of Report
2020-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q nktr-20200930.htm   iXBRL 10-Q 1341494
2 EX-31.1 nktr2020-09x30xexx311.htm EX-31.1 9528
3 EX-31.2 nktr2020-09x30xexx312.htm EX-31.2 9542
4 EX-32.1 nktr2020-09x30xexx321.htm EX-32.1 6045
  Complete submission text file 0000906709-20-000017.txt   5310551

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT nktr-20200930.xsd EX-101.SCH 40730
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT nktr-20200930_cal.xml EX-101.CAL 67466
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT nktr-20200930_def.xml EX-101.DEF 158730
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT nktr-20200930_lab.xml EX-101.LAB 460656
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT nktr-20200930_pre.xml EX-101.PRE 268929
10 EXTRACTED XBRL INSTANCE DOCUMENT nktr-20200930_htm.xml XML 787124
Mailing Address 455 MISSION BAY BOULEVARD SOUTH SAN FRANCISCO CA 94158
Business Address 455 MISSION BAY BOULEVARD SOUTH SAN FRANCISCO CA 94158 4154825300
NEKTAR THERAPEUTICS (Filer) CIK: 0000906709 (see all company filings)

IRS No.: 943134940 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-24006 | Film No.: 201292142
SIC: 2834 Pharmaceutical Preparations